



General Section Original Article 
Journal of Patan Academy of Health Sciences. 2020Dec;7(3):41-46. 
 
Correspondence 
Dr. Pooja Jaiswal 
Dept. of Radiology and Imaging 
Patan Hospital, Patan Academy 







Prof. Dr. Nabees MS Pradhan 
School of Medicine, Patan 
Academy of Health Sciences 
 
Asst. Prof. Dr. Ashis Shrestha 
School of Medicine, Patan 




18 Oct 2020 
 
Accepted 
15 Nov 2020 
 
 
How to cite this article  
Pooja Jaiswal, Shreejana 
Shrestha, Yogita Dwa, Sagun 
Manandhar. Correlation of 
ultrasound imaging with 
histopathological findings in 
gestational trophoblastic 
disease. Journal of Patan 





Correlation of ultrasound imaging with 
histopathological findings in gestational 
trophoblastic disease 
Pooja Jaiswal1  , Shreejana Shrestha2  , Yogita Dwa1 , Sagun Manandhar3  
 
1Asst Prof, 2Assoc Prof, 3MD Radiology and Imaging Resident, Department of 
Radiology and Imaging, Patan Hospital, Patan Academy of Health Sciences, 





Introduction: Gestational trophoblastic diseases include a spectrum of 
pregnancy-related diseases caused by abnormal proliferation of the 
placenta.  The main aim of this study was to correlate ultrasound imaging 
with histopathological findings.  
 
Method: This is the retrospective chart review of findings of 
transabdominal ultrasonography in clinically suspected gestational 
trophoblastic diseases which were confirmed by histopathology after the 
evacuation of a product of conception during 3 years from 2016 to 2019 
at Patan Hospital, Patan Academy of Health Sciences Nepal. The accuracy 
of sonography was correlated with histopathological findings and analyzed 
by Fisher’s Exact or Pearson’s Chi-square tests. The study was approved 
ethically. 
 
Result:  Among 155 clinically suspected gestational trophoblastic diseases, 
ultrasonography was accurate in 141(91.0%) and confirmed by 
histopathology; 14(9.0%) were non-molar miscarriages. In 141 
histologically confirmed trophoblastic disease, 110(71.0 %) were partial 
mole, 15(9.7%) complete mole, 12(7.7%) invasive mole and 3(1.9 %) 
persistent mole, and 1(0.6%) choriocarcinoma. Snowstorm appearance 
and absence of fetus were statistically significant ultrasonography 
findings. 
 
Conclusion:  The ultrasound is a reliable non-invasive first-line imaging 
modality for the diagnosis of gestational trophoblastic diseases and had 
an accuracy of 91% as confirmed by histopathology in this study.  
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Gestational trophoblastic disease (GTD) is a 
rare event found in 8 per 1,000 pregnancies, 
commonly presenting as hydatidiform mole, 
i.e. molar pregnancy.1 The prevalence of molar 
pregnancy, ranging from a high of 12 per 1,000 
pregnancies in Indonesia, India, and Turkey to 
a low of 1-2 in Japan and China; and lowest of 
0.5-1 in North America and Europe.2 Spectrum 
of pregnancy-related diseases caused by the 
abnormal proliferation of trophoblastic tissue 
is seen GTD.3 Broadly the lesions are benign 
i.e., hydatiform mole (complete and partial) to 
gestational trophoblastic neoplasia (GTN) i.e. 
aggressive invasive mole, choriocarcinoma,  
placental site trophoblastic tumor (PSTT), and 
epithelioid trophoblastic tumor (ETT).4 
 
Ultrasound is the first-line imaging 
investigation for the diagnosis of a clinically 
suspected hydatiform mole. It constitutes 80% 
cases of GTD seen most frequently as an 
enlarged uterus with a heterogeneous 
endometrial mass of variable echogenicity, 
classically described as a “snowstorm” 
appearance.1,5-7 The GTD is diagnosed by 
routine pregnancy ultrasound (USG). 5,8-11 
 
Histological examination of evacuated material 
of product of conception is essential to confirm 
the diagnosis. Follow-up monitoring with 
serum human chorionic gonadotropin (hCG) 
every 1-2 weeks after the evacuation is 
essential to detect invasive mole or 
choriocarcinoma.8,11 Early diagnosis and 
prevention of its potential complications is 
important for timely and successful 
management of the condition with 
preservation of fertility.12 
 
This study aimed to find out the accuracy of 






This was a retrospective cross-sectional study 
consisting of 155 sonographically diagnosed 
cases of GTD collected over 3- years between 
2016-2019 at Patan Hospital, Nepal to find out 
the accuracy of USG suspected GTD confirmed 
by histopathological examination. 
 
All patients had transabdominal USG and they 
were examined in longitudinal, transverse, and 
oblique planes. Philips Affinity 50/70 G USG 
machines were used to do USG with a 3.5 MH 
convex probe, performed by the radiologists 
(MD Radiodiagnosis and Imaging), with a 
minimum of 5-years' experience in 
Obstetric/gynecological ultrasound.  
 
The USG features used to diagnose GTD: 13-14 
were: Cystic changes in product of conception 
(POC), Uterus full of dots or snowstorm 
appearance, Presence or absence of a fetus, 
Irregularity or increased echogenicity in the 
chorionic tissue or myometrium, 
heterogeneously enlarged uterus and/or 
placenta 
 
Patients diagnosed as GTD after USG, and 
underwent evacuation of POC, with 
histopathological reports, were included in the 
study. Patients who underwent medical 
management or whose histopathological 
report not present in the chart were excluded. 
 
The correlation between USG findings and 
histopathological diagnosis of GTD was 
analyzed by Fisher’s exact test and Pearson's 
chi-square test. A p-value of less than 0.05 was 
taken as statistically significant. Data entry and 
analysis were done using IBM SPSS version 20 
software. 
 
Ethical approval was obtained from IRC-PAHS 





Ninety-one percent (141 out of 155) of the 
cases diagnosed on ultrasound showed  
“snowstorm” appearance.  This was one of the 
most reliable characteristics in predicting GTD 
(p<0.5).  
 
In the 3-years, there were 155 cases of USG 
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histologically confirmed for molar pregnancy, 
while 14(9%) were non-molar miscarriages. 
 
In 141 cases of histologically confirmed GTD, 
110(71%) were partial mole, 15(9.7%) 
complete mole, 12(7.7%) invasive mole, 
3(1.9%) persistent mole, and 1(0.6%) was 
choriocarcinoma. 
 
The age ranged from 15 to 54 y, mean 
28.37±8.87 y. Six (3.9%) patients had a history 
of molar pregnancy.  Sixty-four (41.3%) 
patients were nulliparous and 91(58.7%) 
multiparous. 
 
In 31(20%) a fetus with molar tissue was seen 
and in24(80%) there was no presence of a 
fetus. Cystic changes in POC was found in 
134(86.5 %) in POC. In 85(54.8%) a snowstorm 
appearance was seen, Table 1. Irregularity of 
myometrium was seen in 21(13.5%). There 
were contents seen in the gestational sac in 
152 (98.1%) and were empty in 3(1.9%) cases. 
The placenta was enlarged in 35(22.6%) and 
normal size in 120(77.4%). In 45(29%) an 
enlarged uterus was seen.  
 
Histologically, 141(91%) were confirmed as 
GTD, Table 2. Snowstorm appearance and 
absence of fetus were statistically significant 
USG findings, p-values were <0.05. Age group, 
parity, history of molar pregnancy, cystic 
changes in POC, irregularity of myometrium, 
enlarged placenta, and uterus were not 





Table 1. Radiological Findings of patients diagnosed with gestational trophoblastic disease (GTD), N=155 
 
 
Characteristics N % 
Presence of fetus   
No 124 80.0 
Yes 31 20.0 
Cystic changes in product of conception   
No 21 13.5 
Yes 134 86.5 
Snowstorm appearances    
No 70 45.2 
Yes 85 54.8 
Irregular myometrium   
No 134 86.5 
Yes 21 13.5 
Empty gestational sac    
No 152 98.1 
Yes 3 1.9 
Enlarged placenta   
No 120 77.4 
Yes 35 22.6 
Enlarged uterus   
No 110 71.0 
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Table 3. Association of histopathology findings with USG features of the GTD patients, N=155 
 
 








Enlarged placenta    
Fisher’s Exact 0.738 Yes 33(94.3) 2(5.7) 35(100) 
No 108(90.0) 12(10.0) 120(100) 
Empty gestational sac    
Fisher’s Exact 0.249 Yes 2(66.7) 1(33.3) 3(100) 
No 139(91.4) 13(8.6) 152(100) 
Irregularity of myometrium     
Fisher’s Exact 0.694 Yes 20(95.2) 1(4.8 21(100) 
No 121(90.3) 13(9.7) 134(100) 
Snowstorm appearance    
Pearson’s 
Chi-square 
0.001* Yes 83(97.6) 2(2.4) 85(100) 
No 58(82.9) 12(17.1) 170(100) 
Cystic changes in POC    
Fisher’s Exact 1.00 Yes 122(91.0) 12(9.0) 134(100) 
No 19(90.5) 2(9.5) 21(100) 





The sonographic appearance of GTD is highly 
variable ranging from a snowstorm 
appearance to a predominantly cystic 
appearing mass with the presence or absence 
of a fetus.12 Ultrasound features of GTD 
depend upon their overall composition. 
Ultrasonography has established and 
developed itself as the most important 
preliminary imaging tool in the identification of 
GTD since a single abnormally elevated serum 
hCG level measured at the time of patient 
presentation is not diagnostic and may be seen 
in multiple gestations as well1,5,7,15,16 An 
overview of previous studies showed that 80% 
of cases of GTD will be seen most frequently as 
an enlarged uterus with a heterogeneous 
endometrial mass of variable echogenicity 
(predominantly echogenic) classically 
described as a “snowstorm” appearance due 
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Other studies found that partial moles were 
more likely to be associated with a fetus that is 
growth retarded or anomalous and an 
enlarged, thickened placenta with numerous 
anechoic cystic lesions.1,6,14   Enlarged placenta 
was relative to the size of the uterine cavity 
associated with cystic spaces "molar 
placenta".19 However, in our study, 71% of the 
cases were partial mole and recognizable fetal 
parts were absent in most of them. This could 
be due to abundant chorionic tissue with loss 
of the normal architecture of fetal parts and 
gestational sac. Differentiation of the 
complete and partial moles can be difficult by 
USG but is of limited clinical significance, as the 
management is similar for complete or partial  
mole.1 
 
In our study, most of the cases turned out to 
be GTD (91%, n= 141) on histopathology of 
POC, and only 9% (n=14) were non-molar. The 
diagnostic accuracy of USG in our study was 
91% based on the sonographic features of 
cystic changes as reported by other studies.17-
18 Cystic changes are more likely to be molar 
tissue. Other studies have also noticed  In 
addition to the small cystic spaces, larger 
irregular fluid collections may be seen in the 
endometrial mass. With increasing gestational 
age, cystic changes become more dominant 
due to the presence of prominent villi, making 
a sonographic diagnosis of GTD easier in the 
second trimester than in the first trimester.1,7 
Studies show <50% of all molar pregnancies 
are detected at routine USG. The detection 
rate is better for complete hydatiform mole  
(58%–95%) than for partial hydatiform mole 
(17%–29%).4 Complete mole shows a more 
pronounced increase with age .20 
 
Our study was limited by the retrospective 
patient data and lacked follow an analysis of 
Beta HCG and USG. Also, multiple machines 
and different operators may have contributed 





Ultrasound is an important first line of non-
invasive imaging for the diagnosis of 
gestational trophoblastic disease with high 
accuracy (91%) as found in our study. Feature 
of  “snowstorm” appearance is the most 
reliable characteristic. 
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